The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study
Top Cited Papers
Open Access
- 26 February 2021
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 13 (5), 7020-7034
- https://doi.org/10.18632/aging.202557
Abstract
Background: The inflammatory reaction is the main cause of acute respiratory distress syndrome and multiple organ failure in patients with Coronavirus disease 2019, especially those with severe and critical illness. Several studies suggested that high-dose vitamin C reduced inflammatory reaction associated with sepsis and acute respiratory distress syndrome. This study aimed to determine the efficacy and safety of high-dose vitamin C in Coronavirus disease 2019. Methods: We included 76 patients with Coronavirus disease 2019, classified into the high-dose vitamin C group (loading dose of 6g intravenous infusion per 12 hr on the first day, and 6g once for the following 4 days, n=46) and the standard therapy group (standard therapy alone, n=30). Results: The risk of 28-day mortality was reduced for the high-dose vitamin C versus the standard therapy group (HR=0.14, 95% CI, 0.03-0.72). Oxygen support status was improved more with high-dose vitamin C than standard therapy (63.9% vs 36.1%). No safety events were associated with high-dose vitamin C therapy. Conclusion: High-dose vitamin C may reduce the mortality and improve oxygen support status in patients with Coronavirus disease 2019 without adverse events.Keywords
This publication has 49 references indexed in Scilit:
- Phase I safety trial of intravenous ascorbic acid in patients with severe sepsisJournal of Translational Medicine, 2014
- Role of Vitamin C in the Function of the Vascular EndotheliumAntioxidants and Redox Signaling, 2013
- Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury*Critical Care Medicine, 2011
- Biomarkers in the Critically Ill Patient: C-reactive ProteinCritical Care Clinics, 2011
- Mechanism of action of vitamin C in sepsis: Ascorbate modulates redox signaling in endotheliumBioFactors, 2009
- Procalcitonin increase in early identification of critically ill patients at high risk of mortality*Critical Care Medicine, 2006
- Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expressionFree Radical Biology & Medicine, 2004
- C-Reactive Protein Levels Correlate With Mortality and Organ Failure in Critically Ill PatientsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2003
- Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at riskCritical Care Medicine, 1996
- Protective role of ascorbic acid against lipid peroxidation and myocardial injuryMolecular and Cellular Biochemistry, 1992